Lung and Cerebral Nocardiosis Caused by Nocardia elegans in a Lung Transplant Recipient: A Case Report and Literature Review

Intern Med. 2023 Feb 1;62(3):431-437. doi: 10.2169/internalmedicine.9813-22. Epub 2022 Jul 14.

Abstract

Patients after lung transplantation are at risk for Nocardia infections. We herein report a case of lung and cerebral nocardiosis caused by Nocardia elegans, a rare species of Nocardia, in a lung transplant recipient. Antibiotic therapy, including sulfamethoxazole-trimethoprim (ST), and brain abscess drainage improved symptoms and imaging findings. A literature review of N. elegans infections showed that 12 of 14 cases (85.7%) were reported from East Asia, particularly Japan (9 cases, 64.2%). The lungs were the predominant site (12/14 cases, 85.7%), and most of the cases were susceptible to ST (9/10 cases, 90%).

Keywords: Nocardia elegans; brain abscess; lung and cerebral nocardiosis; lung transplant; mass spectrometry.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Humans
  • Lung
  • Lung Transplantation* / adverse effects
  • Nocardia Infections* / diagnosis
  • Nocardia Infections* / drug therapy
  • Nocardia*
  • Transplant Recipients
  • Trimethoprim, Sulfamethoxazole Drug Combination

Substances

  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Anti-Bacterial Agents

Supplementary concepts

  • Nocardia elegans